Ilise Lombardo
Director Ejecutivo en Noema Pharma AG .
Origen de la red de primer grado Ilise Lombardo.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 29 | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland.
8
| Holding Company | Biotechnology | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ilise Lombardo a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
| AXSOME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Investment Managers | Private Equity Analyst Chief Investment Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Santa Clara University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Founder Corporate Officer/Principal Chief Operating Officer | |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Part of Pfizer Inc., Medivation Neurology LLC develops and produces biopharmaceutical products. The company is based in San Francisco, CA. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| NOVOCURE LIMITED | Medical Specialties | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| UNC School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director of Finance/CFO Director/Board Member Director of Finance/CFO Chairman Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Chairman Director/Board Member Chairman | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman Chairman | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| NUVATION BIO INC. | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
| Estados Unidos | 39 |
| Reino Unido | 8 |
| Francia | 3 |
| Suecia | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 38 |
| Consumer Services | 10 |
| Finance | 4 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 304 |
| Corporate Officer/Principal | 88 |
| Independent Dir/Board Member | 85 |
| Chairman | 49 |
| Chief Executive Officer | 39 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Antoine Papiernik | 48 |
| Myrtle Potter | 41 |
| George Bickerstaff | 37 |
| Frank Torti | 35 |
| Tony Vernon | 34 |
| Clarence Machado | 30 |
| Catherine Moukheibir | 29 |
| David Hung | 24 |
| Mike Gutch | 24 |
| Lawrence Olanoff | 22 |
| Alan Roemer | 21 |
| Jeff Jonas | 21 |
| Gregory Mark Weinhoff | 21 |
| Roger Jeffs | 18 |
| Jacqualyn Fouse | 18 |
- Bolsa de valores
- Insiders
- Ilise Lombardo
- Conexiones Empresas
